X

Trial Profile

A MULTICENTER OPEN-LABEL EXTENSION STUDY FOR SUBJECTS WHO PARTICIPATED IN STUDY B0151003 (ANDANTE II)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Jan 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TOUR-006 (Primary)
Indications Crohn's disease
Focus Adverse reactions
Acronyms ANDANTE-II
Sponsors Pfizer

Most Recent Events

26 May 2016 This trial was completed in Italy and Ireland (end date: 2016-03-01) and prematurely ended in Greece according to the European Clinical Trials Database
26 Apr 2016 This trial was completed in Belgium,Austria, Sweden and Czech Republic (end date: 2016-03-01), according to the European Clinical Trials Database.
25 Apr 2016 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com